Engxenyeni yokuqala ka-2022, ukuthunyelwa kwamanye amazwe kwemikhiqizo yezempilo njengemithi yaseKorea, imishini yezokwelapha nezimonyo kufinyelele irekhodi eliphezulu. Ama-reagents okuxilonga i-COVID-19 kanye nemithi yokugoma kuthuthukisa ukuthunyelwa ngaphandle.
Ngokusho kweKorea Health Industry Development Institute (KHIDI), ukuthunyelwa kwemboni kwamanye amazwe kufinyelele ku-$ 13.35 billion engxenyeni yokuqala yalo nyaka. Leso sibalo senyuke ngo-8.5% sisuka ku-$12.3 billion kwikota yonyaka edlule futhi kwaba umphumela wesigamu sonyaka ophakeme kunawo wonke. Iqophe ngaphezulu kwe- $ 13.15 billion engxenyeni yesibili ka-2021.
Ngomkhakha, ukuthengiswa kwemithi kufinyelele ku-US$4.35 billion, kwenyuke ngo-45.0% kusuka ku-US$3.0 billion ngesikhathi esifanayo ngo-2021. Ukuthunyelwa kwamanye amazwe kwemishini yezokwelapha kufinyelele ku-USD 4.93 billion, kwenyuke ngo-5.2% unyaka nonyaka. Ngenxa yokuhlukaniswa kwabantu eChina, ukuthunyelwa kwezimonyo kwamanye amazwe kwehle ngo-11.9% kwaya ku-$4.06 billion.
Ukukhula kokuthengiswa kwemithi kwaqhutshwa ama-biopharmaceuticals kanye nemigomo. Ukuthunyelwa kwamanye amazwe kwemithi ye-biopharmaceutical kufike ku-$1.68 billion, kuyilapho ukuthunyelwa kwemithi yokugoma kwamanye amazwe kwaba ezigidini ezingama-$780. Zombili zenza ama-56.4% azo zonke izinto ezithunyelwa ngaphandle kwemithi. Ikakhulukazi, ukuthunyelwa kwemithi yokugoma kwamanye amazwe kukhuphuke ngo-490.8% unyaka nonyaka ngenxa yokwanda kokuthunyelwa kwemithi yokugomela i-COVID-19 ekhiqizwa ngaphansi kokukhiqizwa kwenkontileka.
Emkhakheni wemishini yezokwelapha, ama-reagents okuxilonga anesabelo esikhulu kunazo zonke, afinyelela ku-$ 2.48 billion, akhuphuke ngo-2.8% kusukela esikhathini esifanayo ngo-2021. Ngaphezu kwalokho, ukuthunyelwa kwemishini yokuthwebula i-ultrasound ($ 390 million), izimila ($340 million) kanye ne-X- imishini yama-ray (amaRandi ayizigidi ezingu-330) yaqhubeka ikhula, ikakhulukazi e-US naseChina.
Isikhathi sokuthumela: Aug-23-2022